Effect of Tok-Sen Massage for Non-specific Low Back Pain
Launched by CHINA MEDICAL UNIVERSITY HOSPITAL · May 22, 2024
Trial Information
Current as of February 19, 2025
Completed
Keywords
ClinConnect Summary
Low back pain is the world's leading cause of global productivity loss and the leading cause of years lost with disability (YLDs), with a high prevalence of 28%-42% among those aged 40 to 69 years. The prevalence of different occupations in Taiwan ranges from 35% to 90%; according to the summary of the National Health Insurance Database results report: "The annual prevalence of low back pain is 14% to 45%, and 70% to 85% of people in their lifetime Suffering from low back pain. "Most people who experience low back pain cannot identify the specific source of the injury, and up to 90% of low ...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • chronic low back pain for more than 3 months
- • diagnosis of non-specific low back pain
- • Exclusion Criteria: -
- • Spinal surgery history
- • Joint disease
- • Pregnancy
- • Cancer
- • Systemic disease
- • Mental disease
- • Bone Mass Measurement less than
Trial Officials
Yu-Chen Lee, M.D. & Ph.D.
Study Director
China Medical University, China
About China Medical University Hospital
China Medical University Hospital is a leading healthcare institution dedicated to advancing medical research and enhancing patient care through innovative clinical trials. Affiliated with China Medical University, the hospital is renowned for its comprehensive approach to medical education and research, fostering collaboration between healthcare professionals and academic experts. With state-of-the-art facilities and a commitment to ethical standards, the hospital conducts rigorous clinical trials aimed at improving treatment outcomes across various medical disciplines, contributing significantly to both local and global healthcare advancements.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Taichung City, North Dist, Taiwan
People applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Discussion 0